Good MorningEquity markets tried to advance for the 5th day on Thursday, but the gains were slim, the index closed virtually flat, and the peak of the move may have been reached. The PCE Price Index for July came in hotter than expected and shows consumer-level inflation is accelerating. The data increased the fear of another Fed rate hike, although the market still believes the committee is already done. The odds of another hike are less than 50/50, as indicated by the CME FedWatch Tool, and softened following the release.
The S&P 500 advanced solidly for the week, and an interesting setup is developing. The market could continue higher but will have to break critical resistance levels. Those levels coincide with the summer peak and, if not broken, may produce a double top of another bearish pattern in the index. In that scenario, the market could fall 5% to 10% from current levels before hitting firm support, and there is additional risk. The next FOMC meeting is less than 3 weeks away, and another inflation report is due before then. Featured: Incredible Investment Opportunity - Get In On the Ground Floor (Thumbzup) 
|
Stocks | | | Artificial intelligence has gone mainstream as everyone piles into artificial intelligence stocks. While the concept of artificial intelligence has been around for decades, 2023 was indeed the breakout year and tipping point, making it accessible to anyone and everyone with internet access.... Read the Full Story >> |
|
From Our PartnersThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return. | | | | Get the Details Here >>> |
|
Stocks | | | It’s that time of year. Students are returning to classes again. NFL season is kicking off again. This means demand rises again for transportation. After a three-year hiatus, student loan repayments with interest resume. Football season starts again, which means wagering on games with more b... Read the Full Story >> |
|
Stocks | | | Major pharmaceutical companies including Johnson & Johnson (NYSE: JNJ), Novartis AG (NYSE: NVS), Bristol-Myers Squibb (NYSE: BMY), Merck & Co., Inc. (NYSE: MRK), Eli Lilly & Co. (NYSE: LLY) and Amgen Inc. (NASDAQ: AMGN) were trading normally following... Read the Full Story >> |
|
From Our PartnersLet MarketBeat All Access be your virtual research assistant that keeps track of your stocks and the market for you. Now just $9.97 per month. | | | | Learn More Here |
|
Markets | | | Global shares were trading mostly higher Friday as investors looked toward a U.S. jobs report being released later in the day. France's CAC 40 edged up nearly 0.1% in early trading to 7,321.92, while Germany's DAX was little changed at 15,948.02. Britain's FTSE 100 rose 0.5% to 7,477.41. U.S. shares... Read the Full Story >> |
|
Markets | | | One of the most astonishing and widely discussed subjects in individual stocks revolves around the unpredictability and volatility of a Vietnamese electric vehicle manufacturer. VinFast Auto Ltd. (NASDAQ: VFS) plunged into the public market through a SPAC IPO at the beginning of the month. M... Read the Full Story >> |
|
From Our PartnersMaking profits in the stock market depends on making your entry at the right time. The time is NOW to get into A.I. Artificial Intelligence is turning into one of the most popular trends this year, and it has only just begun.
(**By clicking the link you are subscribing to the The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here) | | | | Go HERE to Reveal Which Stock These Are |
|
Markets | | | Although the marketing world has been changing drastically over the years, some things have stayed the same. I'm talking about human psychology. There are tried and true tactics that win every time based on how we behave and what signals our subconscious behavior and emotional triggers.According to ... Read the Full Story >> |
|
Markets | | | Slowly and steadily, an overheated American job market is returning to room temperature.The Labor Department is expected to report Friday that U.S. employers — companies, nonprofits and government agencies combined — added 170,000 jobs last month, according to a survey of forecasters by the data fir... Read the Full Story >> |
|
Markets | | | An estimated 80% of all internet users see Google Ads on a daily basis. That's about 4.4 billion people. So, if you're not getting any leads or seeing a return on your Google Ads campaigns, it's not for a lack of reach — chances are, you're doing something wrong.There's a reason Google Ads is the wo... Read the Full Story >> |
|
Markets | | | As a web publisher, I've always focused on scaling content production. During 2022, we published a high volume of new articles across our websites — upwards of a thousand new items in a typical month. We employed a team of more than 100 writers and editors to accomplish this gargantuan task. Fast-fo... Read the Full Story >> |
|
Markets | | | The market advanced following the August PCE price index report, but investors and traders should not discount the news. The PCE index remains cool relative to the peaks of the inflation scare, but there are signs that the cooling is over. Inflation may accelerate again; the evidence c... Read the Full Story >> |
|
The Early Bird Stock Of The DayFriday: Stock With Insider Buying Sigilon Therapeutics, Inc., a preclinical stage biotechnology company, develops functional cures for patients with acute and chronic diseases. Its lead product candidate is SIG-002 to replace islet cells for the treatment of type 1 diabetes; and SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-205, SIG-218, SIG-220, and SIG-005, which are to treat the non-neurological manifestations of... | | View Today's Stock Pick |
|
No comments:
Post a Comment